Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 22.04B | 21.68B | 21.31B | 20.20B | 19.40B | 17.32B |
Gross Profit | 3.95B | 4.13B | 3.78B | 3.59B | 3.16B | 2.71B |
EBITDA | 709.33M | 1.05B | 945.85M | 773.14M | 788.02M | 552.17M |
Net Income | 649.74M | 629.56M | 561.24M | 462.84M | 489.27M | 317.12M |
Balance Sheet | ||||||
Total Assets | 18.24B | 18.64B | 18.46B | 18.17B | 16.26B | 15.85B |
Cash, Cash Equivalents and Short-Term Investments | 6.88B | 6.12B | 6.23B | 7.08B | 5.82B | 5.31B |
Total Debt | 177.00M | 165.08M | 228.71M | 322.87M | 236.91M | 317.23M |
Total Liabilities | 6.30B | 6.44B | 6.56B | 7.21B | 6.04B | 6.20B |
Stockholders Equity | 11.64B | 11.90B | 11.59B | 10.70B | 9.99B | 9.40B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 276.29M | -852.62M | 901.00M | 424.16M | 595.48M |
Operating Cash Flow | 0.00 | 354.00M | -772.80M | 932.17M | 467.19M | 614.25M |
Investing Cash Flow | 0.00 | -605.64M | -676.11M | 68.85M | 12.98M | 9.78M |
Financing Cash Flow | 0.00 | -247.89M | -191.28M | -5.52M | -145.75M | -164.61M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | ¥5.99B | 6.67 | 2.48% | 4.59% | 21.89% | ||
73 Outperform | ¥20.11B | 7.02 | 4.70% | 7.61% | -32.07% | ||
72 Outperform | ¥14.01B | 21.55 | 4.09% | -10.35% | -39.24% | ||
71 Outperform | ¥15.46B | 7.30 | 7.39% | -3.83% | 4.11% | ||
70 Outperform | ¥6.28B | 9.97 | 1.82% | 1.70% | 12.23% | ||
65 Neutral | $10.75B | 15.65 | 5.18% | 1.92% | 3.09% | -27.41% | |
59 Neutral | ¥7.23B | 19.70 | 3.03% | 0.66% | 41.70% |